Finding fusin/CXCR4, the first "2nd receptor" for HIV entry

被引:3
作者
Berger, Edward A. [1 ]
机构
[1] NIAID, Mol Struct Sect, Viral Dis Lab, NIH, Bethesda, MD 20892 USA
来源
FRONTIERS IN IMMUNOLOGY | 2015年 / 6卷
关键词
coreceptor; tropism; T cell line; macrophage; CCR5; CD4; Env glycoprotein; cell fusion; RECOMBINANT VACCINIA VIRUS; T-CELL LINES; ENVELOPE GLYCOPROTEIN; PRIMARY MACROPHAGES; TYPE-1; TROPISM; FUSION; INFECTION; SYSTEM;
D O I
10.3389/fimmu.2015.00283
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页数:4
相关论文
共 50 条
  • [1] CXCR4/fusin is not a species-specific barrier in murine cells for HIV-1 entry
    Tachibana, K
    Nakajima, T
    Sato, A
    Igarashi, K
    Shida, H
    Iizasa, H
    Yoshida, N
    Yoshie, O
    Kishimoto, T
    Nagasawa, T
    JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (10) : 1865 - 1870
  • [2] Discovery of Novel HIV Entry Inhibitors for the CXCR4 Receptor by Prospective Virtual Screening
    Perez-Nueno, Violeta I.
    Pettersson, Sofia
    Ritchie, David W.
    Borrell, Jose I.
    Teixido, Jordi
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2009, 49 (04) : 810 - 823
  • [3] CXCR4-targeting nanobodies differentially inhibit CXCR4 function and HIV entry
    Van Hout, Anneleen
    Klarenbeek, Alex
    Bobkov, Vladimir
    Doijen, Jordi
    Arimont, Marta
    Zhao, Chunxia
    Heukers, Raimond
    Rimkunas, Rebecca
    de Graaf, Chris
    Verrips, Theo
    van der Woning, Bas
    de Haard, Hans
    Rucker, Joseph B.
    Vermeire, Kurt
    Handel, Tracy
    Van Loy, Tom
    Smit, Martine J.
    Schols, Dominique
    BIOCHEMICAL PHARMACOLOGY, 2018, 158 : 402 - 412
  • [4] HIV-1 Utilizes the CXCR4 Chemokine Receptor to Infect Multipotent Hematopoietic Stem and Progenitor Cells
    Carter, Christoph C.
    McNamara, Lucy A.
    Onafuwa-Nuga, Adewunmi
    Shackleton, Mark
    Riddell, James
    Bixby, Dale
    Savona, Michael R.
    Morrison, Sean J.
    Collins, Kathleen L.
    CELL HOST & MICROBE, 2011, 9 (03) : 223 - 234
  • [5] Targeting CXCR4 in HIV Cell-Entry Inhibition.
    Steen, A.
    Schwartz, T. W.
    Rosenkilde, M. M.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2009, 9 (14) : 1605 - 1621
  • [6] HIV Cell Fusion Assay: Phenotypic Screening Tool for the Identification of HIV Entry Inhibitors via CXCR4
    Smith, Elizabeth B.
    Ogert, Robert A.
    Pechter, David
    Villafania, Artjohn
    Abbondanzo, Susan J.
    Lin, Karen
    Rivera-Gines, Aida
    Rebsch-Mastykarz, Cheryl
    Monsma, Frederick J., Jr.
    JOURNAL OF BIOMOLECULAR SCREENING, 2014, 19 (01) : 108 - 118
  • [7] Co-expression of CXCR4/fusin and galactosylceramide in the human intestinal epithelial cell line HT-29
    Delezay, O
    Koch, N
    Yahi, N
    Hammache, D
    Tourres, C
    Tamalet, C
    Fantini, J
    AIDS, 1997, 11 (11) : 1311 - 1318
  • [8] Blockade of X4-Tropic HIV-1 Cellular Entry by GSK812397, a Potent Noncompetitive CXCR4 Receptor Antagonist
    Jenkinson, Stephen
    Thomson, Michael
    McCoy, David
    Edelstein, Mark
    Danehower, Susan
    Lawrence, Wendell
    Wheelan, Pat
    Spaltenstein, Andrew
    Gudmundsson, Kristjan
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (02) : 817 - 824
  • [9] Characterization of a CXCR4 antagonist TIQ-15 with dual tropic HIV entry inhibition properties
    Zhou, Zheng
    Guo, Jia
    Hetrick, Brian
    Tiwari, Sameer
    Haikerwal, Amrita
    Han, Yang
    Bond, Vincent C.
    Huang, Ming B.
    Mankowski, Marie K.
    Snyder, Beth A.
    Hogan, Priscilla A.
    Sharma, Savita K.
    Liotta, Dennis C.
    Reid, Terry-Elinor
    Wilson, Lawrence J.
    Wu, Yuntao
    PLOS PATHOGENS, 2024, 20 (08)
  • [10] A Novel Synthetic Bivalent Ligand To Probe Chemokine Receptor CXCR4 Dimerization and Inhibit HIV-1 Entry
    Choi, Won-Tak
    Kumar, Santhosh
    Madani, Navid
    Han, Xiaofeng
    Tian, Shaomin
    Dong, Chang-Zhi
    Liu, Dongxiang
    Duggineni, Srinivas
    Yuan, Jian
    Sodroski, Joseph G.
    Huang, Ziwei
    An, Jing
    BIOCHEMISTRY, 2012, 51 (36) : 7078 - 7086